The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 May 2018 07:00

RNS Number : 3366O
Tarsus Group PLC
17 May 2018
 

17 May 2018

Tarsus Group plc

("Tarsus" or "the Group")

Trading Update

Tarsus Group plc (LSE: TRS), the international business-to-business media group, is today providing a trading update on its current financial year to date.

Trading since the publication of the Group's Annual Results on 28 February 2018 has been in line with the Board's expectations and forward bookings continue to be ahead of our targeted growth range. As previously guided, trading for 2018 is heavily second half weighted with revenues predominantly dollar denominated.

In the US, as expected, the Connect business has traded strongly and the Medical portfolio has continued to grow. In China, the Spring Hometex event was a record edition and trading in Dubai and Mexico has been positive. The trading pattern in Turkey is similar to last year with a weak first half but more positive forward bookings for the larger shows in the second half.

Douglas Emslie, Tarsus Group Managing Director, said:

"We are encouraged by our forward bookings for the year.

"The next phase of our Quickening the Pace strategy, launched in January this year, is focused on increasing the scale of our individual events as well as driving the momentum of the overall portfolio through replication of our leading brands.

"The outlook for the global exhibition industry continues to be positive and with a deepening presence in the US and China - the two largest individual markets - we are well placed to continue to deliver encouraging growth in the years ahead."

The Group plans to announce its Interim Results for the six months ended 30 June 2018 on 26 July 2018.

 

For further information:

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0) 20 8846 2700

Dan O'Brien, Group Finance Director

 

 

Neville Harris, Investor Relations

+44 (0)7909 976044 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUWUAUPRGQQ
Date   Source Headline
30th Jul 20147:00 amRNSHalf Yearly Report
11th Jul 20144:17 pmRNSAdditional Listing and Voting Rights
30th Jun 20145:05 pmRNSDirector/PDMR Shareholding
30th Jun 20145:00 pmRNSTotal Voting Rights
26th Jun 20147:00 amRNSNotice of interim results
24th Jun 20146:01 pmRNSDirector/PDMR Shareholding
24th Jun 201412:03 pmRNSDirectorate Change
23rd Jun 20143:44 pmRNSResult of AGM
20th Jun 20144:17 pmRNSDirector/PDMR Shareholding
5th Jun 20143:35 pmRNSScrip Dividend Circular
21st May 20145:26 pmRNSNotice of AGM
15th May 20147:00 amRNSInterim Management Statement
12th May 20141:00 pmRNSBlocklisting Interim Review
7th May 20147:46 amRNSNotice of IMS
30th Apr 20145:03 pmRNSTotal Voting Rights
24th Mar 20144:26 pmRNSDirector/PDMR Shareholding
18th Mar 20145:15 pmRNSCompletion of acquisition of SIUF
17th Mar 20145:10 pmRNSAnnual Financial Report
12th Mar 20144:35 pmRNSDirector/PDMR Shareholding
5th Mar 20144:15 pmRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSFinal Results
26th Feb 201411:41 amRNSNotice of Results
19th Feb 20144:03 pmRNSHolding(s) in Company
13th Feb 201410:11 amRNSAdmission of Placing Shares
10th Feb 201411:08 amRNSCompletion of Placing
10th Feb 20147:00 amRNSProposed Placing of New Ordinary Shares
10th Feb 20147:00 amRNSAcquisitions
23rd Jan 201410:04 amRNSApplication for Admission
8th Jan 20147:01 amRNSCorporate Activity
8th Jan 20147:00 amRNSYear end trading update
19th Dec 20138:41 amRNSScrip Dividend
2nd Dec 20134:55 pmRNSTotal Voting Rights
26th Nov 20137:00 amRNSAcquisition
8th Nov 20132:55 pmRNSBlocklisting Interim Review
4th Nov 20137:00 amRNSInterim Management Statement
30th Sep 201311:13 amRNSTotal Voting Rights
16th Sep 20134:51 pmRNSDirector/PDMR Shareholding
22nd Aug 20137:00 amRNSInterim Financial Report
2nd Aug 20132:59 pmRNSTotal Voting Rights
2nd Aug 20132:58 pmRNSApplication for Admission
31st Jul 20137:01 amRNSDirectorate Change
31st Jul 20137:00 amRNSHalf Yearly Report
28th Jun 201311:35 amRNSTotal Voting Rights
28th Jun 20137:00 amRNSPre-close Trading Update
24th Jun 20133:06 pmRNSChange of Auditor
24th Jun 20133:04 pmRNSResult of AGM
19th Jun 201310:40 amRNSNotice of Results
6th Jun 20136:13 pmRNSCirc re. Scrip Dividend
23rd May 20135:31 pmRNSNotice of AGM
17th May 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.